<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00526695</url>
  </required_header>
  <id_info>
    <org_study_id>17-2005</org_study_id>
    <nct_id>NCT00526695</nct_id>
  </id_info>
  <brief_title>Effects of Sevoflurane in Subanesthetic Concentrations on the Forearm Perfusion</brief_title>
  <official_title>Effects of Sevoflurane in Subanesthetic Concentrations on the Forearm Perfusion, Leukocyte/Thrombocyte Activation, and Endothelial Function After Tourniquet-Induced Ischemia/Reperfusion Injury in the Forearm of Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sevoflurane preconditioning and cardiovascular protection against ischemia/reperfusion
      injury.

      Study hypothesis: The volatile anesthetic sevoflurane at subanesthetic concentrations
      achieves endothelial protection against ischemia/reperfusion injury and reduces inflammatory
      markers in the circulation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Healthy volunteers are included in the study to investigate endothelial function and platelet
      activation after preconditioning by sevoflurane in subanesthetic concentrations.

      Forearm perfusion, endothelial function and leukocyte/thrombocyte activation after
      tourniquet-induced ischemia/reperfusion injury of the forearm are measured using healthy
      volunteers in a cross-over design.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2005</start_date>
  <completion_date type="Anticipated">December 2008</completion_date>
  <primary_completion_date type="Anticipated">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>marker expression on blood cells</measure>
    <time_frame>December 2008</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Ischemia/Reperfusion Injury</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane (Preconditioning)</intervention_name>
    <description>Inhalation of sub-anesthetic doses of sevoflurane</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria: male

          -  Non-smoker

          -  No asthma

          -  NPO

          -  Volunteer

        Exclusion criteria:

          -  Female

          -  Chronic medication

          -  Asthma

          -  Smoking
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Zaugg, PD Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Zaugg, PD Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <phone>+41 (0)44 255 11 11</phone>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Zurich</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Zaugg, MD</last_name>
      <email>michael.zaugg@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Michael Zaugg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2007</study_first_submitted>
  <study_first_submitted_qc>September 6, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2007</study_first_posted>
  <last_update_submitted>July 17, 2008</last_update_submitted>
  <last_update_submitted_qc>July 17, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 18, 2008</last_update_posted>
  <responsible_party>
    <name_title>Michael Zaugg</name_title>
    <organization>Anesthesiology, Univ. Hospital Zurich</organization>
  </responsible_party>
  <keyword>Ischemia/Reperfusion</keyword>
  <keyword>Organ Protection</keyword>
  <keyword>Anesthetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

